Zavesca and condition aggravated Patient Reports February 11, 2012

Zavesca Side Effects Report #4728356-0
Zavesca side effect was reported by a Health Professional from UNITED STATES on July 11, 2005. Female patient, child 2 years of age, weighting 35.05 lb, was diagnosed with tay-sachs disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: condition aggravated, convulsion. Zavesca dosage: 50 MG, TID, ORAL. During the same period patient was treated with PHENOBARBITAL, TOPAMAX, TRILEPTAL, PULMICORT, PREVACID, NASONEX, DUONEB, CULTUREL. Patient recovered.

Zavesca Side Effects Report #4749874-5
Zavesca side effect was reported by a Physician from UNITED STATES on Aug 03, 2005. Female patient, child 2 years of age, weighting 34.39 lb, was diagnosed with tay-sachs disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: condition aggravated, tonic convulsion. Zavesca dosage: 50 MG, TID , ORAL. During the same period patient was treated with PHENOBARBITAL, TOPAMAX, TRILEPTAL, PULMICORT, PREVACID, NASONEX, DUONEB, CULTUREL. Patient recovered.

Zavesca Side Effects Report #4707597-2
Zavesca side effect was reported by a Physician from CANADA on June 17, 2005. Female patient, child 10 years of age, weighting 75.40 lb, was diagnosed with tay-sachs disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: condition aggravated, convulsion. Zavesca dosage: 100 MG TID ORAL. During the same period patient was treated with TEGRETOL. Patient recovered.

Zavesca Side Effects Report #5139725-1
Zavesca side effect was reported by a Physician from FRANCE on Oct 13, 2006. Female patient, child 5 years of age, weighting 33.07 lb, was diagnosed with interferon gamma receptor deficiency and was treated with Zavesca. After drug was administered, patient experienced the following side effects: condition aggravated, hypertrichosis, mycobacterium avium complex infection. Zavesca dosage: unknown. Patient died on 06/04/2006.


Zavesca Side Effects Report #4704665-6
Zavesca side effect was reported by a Physician from on June 16, 2005. Female patient, 63 years of age, weighting 94.80 lb, was diagnosed with gaucher's disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: condition aggravated, depression , parkinson's disease , weight decreased. Zavesca dosage: unknown. During the same period patient was treated with HYZAAR, FOSAMAX, VITAMIN, VITAMIN D3, MODAPAR, ACETAMINOPHEN W. Patient was hospitalized. Patient recovered.

Zavesca Side Effects Report #4728133-0
Zavesca side effect was reported by a Physician from FRANCE on July 11, 2005. Female patient, 63 years of age, weighting 96.56 lb, was diagnosed with gaucher's disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: condition aggravated, depression , parkinson's disease , weight decreased. Zavesca dosage: 100 MG, TID, ORAL. During the same period patient was treated with HYZAAR, FOSAMAX, CALCIUM, VITAMIN D3, MODOPAR, ANTIDEPRESSANTS. Patient recovered.

Zavesca Side Effects Report #5319705-3
Zavesca side effect was reported by a Physician from FRANCE on Apr 20, 2007. Female patient, 17 years of age, weighting 106.9 lb, was diagnosed with gaucher's disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: acquired claw toe, chronic inflammatory demyelinating polyradiculoneuropathy, condition aggravated, diarrhoea, epilepsy , flatulence, guillain-barre syndrome , joint sprain. Zavesca dosage: 100 MG, TID, ORAL. During the same period patient was treated with LAMICTAL, TOPIRAMATE, CLONAZEPAM, KEPPRA. Patient was hospitalized. Patient recovered.

Zavesca Side Effects Report #5122624-9
Zavesca side effect was reported by a Consumer or non-health professional from FRANCE on Sept 21, 2006. Female patient, 17 years of age, weighting 106.9 lb, was diagnosed with gaucher's disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: acquired claw toe, chitotriosidase decreased, condition aggravated, demyelinating polyneuropathy, diarrhoea, epilepsy , flatulence, guillain-barre syndrome , joint sprain. Zavesca dosage: 100 MG, TID, ORAL; 100 MG, QD, ORAL. During the same period patient was treated with LAMICTAL, TOPIRAMATE, CLONAZEPAM, KEPPRA. Patient was hospitalized. Patient recovered.

Zavesca Side Effects Report #5521881-4
Zavesca side effect was reported by a Physician from FRANCE on Oct 31, 2007. Female patient, 17 years of age, weighting 106.9 lb, was diagnosed with gaucher's disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: condition aggravated, demyelinating polyneuropathy, diarrhoea, epilepsy , flatulence, foot fracture, guillain-barre syndrome , joint sprain, neuropathy peripheral. Zavesca dosage: 100 MG, TID, ORAL; 100 MG, QD, ORAL. During the same period patient was treated with LAMICTAL, TOPIRAMATE, CLONAZEPAM, KEPPRA. Patient was hospitalized. Patient recovered.


Zavesca Side Effects Report #4777912-2
Zavesca side effect was reported by a Consumer or non-health professional from FRANCE on Sept 05, 2005. Female patient, 17 years of age, weighting 106.9 lb, was diagnosed with gaucher's disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: condition aggravated, demyelinating polyneuropathy, epilepsy , guillain-barre syndrome , paraesthesia. Zavesca dosage: unknown. During the same period patient was treated with LAMCAL, TOPIRAMATE, CLONAZEPAM, KEPPRA. Patient was hospitalized. Patient recovered.

Zavesca Side Effects Report #4824677-1
Zavesca side effect was reported by a Consumer or non-health professional from FRANCE on Oct 17, 2005. Female patient, 17 years of age, weighting 106.9 lb, was diagnosed with gaucher's disease and was treated with Zavesca. After drug was administered, patient experienced the following side effects: acquired claw toe, condition aggravated, demyelinating polyneuropathy, diarrhoea, epilepsy , flatulence, guillain-barre syndrome . Zavesca dosage: 100 MG, TID, ORAL. During the same period patient was treated with LAMICTAL, TOPIRAMATE, CLONAZEPAM, KEPPRA. Patient was hospitalized. Patient recovered.